Peucedanocoumarin III is an inhibitor of (alpha)-synuclein and Huntington protein aggregates that enhances the clearance of nuclear and cytoplasmic beta23 aggregates and prevents cytotoxicity induced by disease-associated proteins (i.e., mutant Huntington proteins and alpha-synuclein). Peucedanocoumarin III may be used in Parkinsons disease research[1].
Molekulargewicht:
386.40
Reinheit:
95.07
CAS Nummer:
[130464-57-2]
Formel:
C21H22O7
Target-Kategorie:
alpha-synuclein
Anwendungsbeschreibung:
MCE Product type: Natural Products
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten